Viking Therapeutics, Inc. share price logo

Viking Therapeutics, Inc. Share Price

NASDAQ: VKTX

Mid Cap

$35.41

+1.53

(+4.52%)

as on

Viking Therapeutics, Inc. Stock Performance

as on December 4, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $33.81
    $35.84
    downward going graph

    4.52%

    Downside

    1.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $18.92
    $52.58
    downward going graph

    46.57%

    Downside

    48.49%

    Upside

    downward going graph

Viking Therapeutics, Inc. share price movements today

Previous Close
$33.88
Open
$34.11
Volume
2.8M
Day's Low - High
$33.81 - $35.84
52 Week Low - High
$18.92 - $52.58

Viking Therapeutics, Inc. Historical Returns

1 Month Return
+ 2.25 %
3 Month Return
+ 33.47 %
1 Year Return
-30.89 %
3 Year Return
+ 731.22 %
5 Year Return
+ 459.4 %

Viking Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Viking Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.8B

EPS (TTM)

-2.61

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.03

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-29.23%

Viking Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Viking Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Viking Therapeutics, Inc. image
Viking Therapeutics, Inc.
BUY$3.8B459.4%NA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$44.1B415.15%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.4B265.31%1408.881.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.1B102.84%29.9331.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.6B46.95%17.9832.13%

Stock Returns calculator for Viking Therapeutics, Inc. Stock including INR - Dollar returns

The Viking Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Viking Therapeutics, Inc. investment value today

Current value as on today

₹75,612

Returns

₹24,388

(-24.39%)

Returns from Viking Therapeutics, Inc. Stock

₹30,894 (-30.89%)

Dollar Returns*

₹6,506 (+6.51%)

Analyst Recommendation on Viking Therapeutics, Inc. Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Viking Therapeutics, Inc.. Average target price of $93.39

Viking Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Viking Therapeutics, Inc..

What analysts predicted

62.08%UPSIDE

Target Price

$93.39

Current Price

$35.41

Analyzed by

17 Analysts

Target

$93.39

Viking Therapeutics, Inc. target price $93.39, a slight upside of 62.08% compared to current price of $35.41. According to 17 analysts rating.

Viking Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Investment in Viking Therapeutics, Inc. Shares on INDmoney has dropped by -35.69% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-35.69% versus previous 30 day period

Search interest for Viking Therapeutics, Inc. Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:64% versus previous 30 day period

Viking Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-23
-27
-29
-34
-34
-36
-46
-55
-74
-98
EBITDA
-23
-27
-24
-33
-33
-24
-35
-55
-65
-90
Interest Expense
0
0
0
0
0
0
0
-
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-19
-22
-24
-27
-22
-24
-35
-45
-65
-90
Income Tax Expense
0
0
1
0
-
0
-
-
-
-
Net Income
-19
-22
-24
-27
-22
-24
-35
-45
-65
-90
Net Profit Margin
0.00%
0.00%
-5643.35%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Viking Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
0
0
-
-
-
Gross Profit
-
-
-
-
0
0
0
0
0
0
Operating Income
-11
-13
-19
-26
-32
-42
-55
-70
-100
-150
EBITDA
-22
1
0
4
-25
3
-54
-68
-100
-109
Interest Expense
0
1
1
0
0
0
0
1
0
0
Depreciation
-
-
-
-
0
0
0
0
0
0
Income Before Tax
-23
-14
-20
-22
-25
-39
-54
-68
-85
-109
Income Tax Expense
0
1
1
-2
6
-3
0
-1
0
-109
Net Income
-23
-14
-20
-22
-25
-39
-54
-68
-85
-109
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-368045.85%
-513877.21%
0.00%
0.00%
0.00%

Viking Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-22
-24
-27
-22
-24
-35
-45
-65
-90
Operating Cash Flow
-19
-17
-6
-28
-21
-31
-52
-47
-94
Investing Cash Flow
-12
35
-459
-126
25
6
63
42
160
Financing Cash Flow
0
0
606
2
2
1
0
0
0
Change in Cash
-32
18
140
-151
6
-23
11
-4
66

Viking Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-14
-20
-22
-25
-39
-54
-68
-85
-109
Operating Cash Flow
-11
-14
-18
-24
-21
-47
-48
-73
-87
Investing Cash Flow
3
-1
-265
7
41
37
54
-179
-553
Financing Cash Flow
10
22
300
0
0
6
4
271
612
Change in Cash
2
5
15
-16
20
-2
10
18
-28

Global Institutional Holdings in Viking Therapeutics, Inc.

Funds
Holdings
Vanguard Group Inc
9.04%
FMR Inc
8.73%
BlackRock Inc
4.84%
State Street Corp
3.36%
Morgan Stanley - Brokerage Accounts
2.89%
See all

Viking Therapeutics, Inc. News & Key Events

    Insights on Viking Therapeutics, Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, VKTX stock has moved up by 731.2%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Insmed Incorporated has given 174.4% return, outperforming this stock by 205.3%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Insmed Incorporated has given 915.1% return, outperforming this stock by 183.9%

    About Viking Therapeutics, Inc.

    novel therapeutics for metabolic and endocrine disorders.
    OrganisationViking Therapeutics, Inc.
    Headquarters9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121
    IndustryHealth Technology
    CEODr. Brian Lian Ph.D.
    E-voting on sharesClick here to vote

    Key Management of Viking Therapeutics, Inc.

    Name

    Title

    Dr. Geoffrey E. Barker Ph.D.

    Chief Development Officer

    Dr. Brian Lian Ph.D.

    President, CEO & Director

    Mr. Gregory S. Zante CPA, CPA

    Chief Financial Officer

    Ms. Marianne Mancini

    Chief Operating Officer

    Mr. Michael Morneau

    Vice President of Finance & Administration

    FAQs

    What is Viking Therapeutics, Inc. share price today?

    Viking Therapeutics, Inc. share price today is $35.41 as on at the close of the market. Viking Therapeutics, Inc. share today touched a day high of $35.84 and a low of $33.81.

    What is the 52 week high and 52 week low for Viking Therapeutics, Inc. share?

    Viking Therapeutics, Inc. share touched a 52 week high of $52.58 on and a 52 week low of $18.92 on . Viking Therapeutics, Inc. stock price today i.e. is closed at $35.41,which is 32.66% down from its 52 week high and 87.16% up from its 52 week low.

    What is Viking Therapeutics, Inc.'s market capitalisation today?

    Viking Therapeutics, Inc. market capitalisation is $0.00T as on .

    How to invest in Viking Therapeutics, Inc. Stock (VKTX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Viking Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viking Therapeutics, Inc. Shares that will get you 0.0424 shares as per Viking Therapeutics, Inc. share price of $35.41 per share as on December 4, 2025 at 2:29 am IST.

    What is the minimum amount required to buy Viking Therapeutics, Inc. Stock (VKTX) from India?

    Indian investors can start investing in Viking Therapeutics, Inc. (VKTX) shares with as little as ₹90.19 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹901.90 in Viking Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Viking Therapeutics, Inc. share’s latest price of $35.41 as on December 4, 2025 at 2:29 am IST, you will get 0.2824 shares of Viking Therapeutics, Inc.. Learn more about fractional shares .

    What are the returns that Viking Therapeutics, Inc. has given to Indian investors in the last 5 years?

    Viking Therapeutics, Inc. stock has given 459.4% share price returns and 21.31% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?